A novel method for strict intranasal delivery of non-replicating RSV vaccines in cotton rats and non-human primates-Reference-Cited by-同舟云学术

A novel method for strict intranasal delivery of non-replicating RSV vaccines in cotton rats and non-human primates

Published:2018-05 Issue:20 Volume:36 Page:2876-2885
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Citron Michael P.,Patel Manishkumar,Purcell Mona,Lin Shu-An,Rubins Daniel J.,McQuade Paul,Callahan Cheryl,Gleason Alexa,Petrescu Ioan,Knapp Walter,Orekie Chinedu,Chamarthy Sai,Wen Zhiyun,Touch Sinoeun,Pine Matthew,Fontenot Jane,Douglas Cameron,Liang Xiaoping,Espeseth Amy S.

Funder

Merck and Co. Inc

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference71 articles.

1. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979–1997;Shay;J Infect Dis,2001

2. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia;Groothuis;Pediatrics,1988

3. The burden of respiratory syncytial virus infection in young children;Hall;N Engl J Med,2009

4. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age;Hall;Pediatrics,2013

5. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis;Nair;Lancet,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Compartmentalized SARS-CoV-2 replication in upper versus lower respiratory tract after intranasal inoculation or aerosol exposure;The Journal of Infectious Diseases;2024-01-23

2. Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults;Vaccine;2023-10

3. Compartmentalized SARS-CoV-2 replication in upper versus lower respiratory tract after intranasal inoculation or aerosol exposure;2023-09-12

4. Nano-vaccination Strategies: Applications and Challenges for Intranasal Immunization;Current Pharmaceutical Biotechnology;2023-07

5. From animal studies into clinical trials: the relevance of animal models to develop vaccines and therapies to reduce disease severity and prevent hRSV infection;Expert Opinion on Drug Discovery;2022-09-20